Neuberger Berman Group’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.37M | Buy |
261,611
+237,939
| +1,005% | +$5.45M | ﹤0.01% | 1033 |
|
|
2026
Q1 | $521K | Sell |
23,672
-24,001
| -50% | -$418K | ﹤0.01% | 1630 |
|
|
2025
Q4 | $562K | Buy |
47,673
+3,005
| +7% | +$38.6K | ﹤0.01% | 1591 |
|
|
2025
Q3 | $708K | Buy |
44,668
+2,701
| +6% | +$39.2K | ﹤0.01% | 1475 |
|
|
2025
Q2 | $481K | Buy |
41,967
+7,802
| +23% | +$87.9K | ﹤0.01% | 1588 |
|
|
2025
Q1 | $462K | Sell |
34,165
-3,864
| -10% | -$64.2K | ﹤0.01% | 1545 |
|
|
2024
Q4 | $643K | Buy |
38,029
+2,637
| +7% | +$51.3K | ﹤0.01% | 1456 |
|
|
2024
Q3 | $719K | Sell |
35,392
-1,450
| -4% | -$29.6K | ﹤0.01% | 1404 |
|
|
2024
Q2 | $832K | Buy |
36,842
+212
| +0.6% | +$5.55K | ﹤0.01% | 1332 |
|
|
2024
Q1 | $962K | Sell |
36,630
-3,475
| -9% | -$99K | ﹤0.01% | 1297 |
|
|
2023
Q4 | $1.26M | Sell |
40,105
-84
| -0.2% | -$2.28K | ﹤0.01% | 1215 |
|
|
2023
Q3 | $1.13M | Sell |
40,189
-334
| -0.8% | -$11.5K | ﹤0.01% | 1219 |
|
|
2023
Q2 | $1.49M | Buy |
40,523
+3,679
| +10% | +$112K | ﹤0.01% | 1147 |
|
|
2023
Q1 | $1.1M | Sell |
36,844
-3,617
| -9% | -$119K | ﹤0.01% | 1225 |
|
|
2022
Q4 | $1.24M | Sell |
40,461
-1,361
| -3% | -$40.8K | ﹤0.01% | 1183 |
|
|
2022
Q3 | $1.03M | Buy |
41,822
+5,578
| +15% | +$184K | ﹤0.01% | 1249 |
|
|
2022
Q2 | $1.16M | Buy |
36,244
+1,513
| +4% | +$55.6K | ﹤0.01% | 1244 |
|
|
2022
Q1 | $1.09M | Sell |
34,731
-63
| -0.2% | -$1.97K | ﹤0.01% | 1326 |
|
|
2021
Q4 | $1.16M | Buy |
34,794
+25,824
| +288% | +$804K | ﹤0.01% | 1323 |
|
|
2021
Q3 | $259K | Sell |
8,970
-751
| -8% | -$24.3K | ﹤0.01% | 1641 |
|
|
2021
Q2 | $337K | Buy |
+9,721
| New | +$322K | ﹤0.01% | 1577 |
|
|
2020
Q2 | – | Sell |
-11,235
| Closed | -$100K | – | 1540 |
|
|
2020
Q1 | $100K | Buy |
+11,235
| New | +$162K | ﹤0.01% | 1478 |
|
|
2019
Q3 | – | Sell |
-668,471
| Closed | -$16M | – | 1542 |
|
|
2019
Q2 | $16M | Sell |
668,471
-15,738
| -2% | -$464K | 0.02% | 658 |
|
|
2019
Q1 | $25.4M | Sell |
684,209
-9,897
| -1% | -$360K | 0.03% | 546 |
|
|
2018
Q4 | $19.6M | Buy |
694,106
+678,325
| +4,298% | +$21.5M | 0.03% | 569 |
|
|
2018
Q3 | $622K | Sell |
15,781
-432,012
| -96% | -$18.9M | ﹤0.01% | 1287 |
|
|
2018
Q2 | $19.9M | Sell |
447,793
-29,432
| -6% | -$1.46M | 0.02% | 635 |
|
|
2018
Q1 | $23.3M | Buy |
477,225
+108,181
| +29% | +$5.41M | 0.03% | 599 |
|
|
2017
Q4 | $18.5M | Buy |
369,044
+27,846
| +8% | +$1.46M | 0.02% | 644 |
|
|
2017
Q3 | $17.3M | Buy |
341,198
+263,729
| +340% | +$12.4M | 0.02% | 651 |
|
|
2017
Q2 | $2.94M | Buy |
77,469
+67,890
| +709% | +$2.68M | ﹤0.01% | 941 |
|
|
2017
Q1 | $369K | Buy |
9,579
+141
| +1% | +$4.24K | ﹤0.01% | 1372 |
|
|
2016
Q4 | $208K | Buy |
+9,438
| New | +$194K | ﹤0.01% | 1520 |
|
|
2015
Q4 | – | Sell |
-40,755
| Closed | -$264K | – | 1504 |
|
|
2015
Q3 | $264K | Buy |
+40,755
| New | +$427K | ﹤0.01% | 1399 |
|
Other funds holding CC
CCPM
Neuberger Berman Group's CC Position: Q2 2026 in Review
Neuberger Berman Group increased its Chemours (CC) stake by 1,005% in Q2 2026, buying an estimated $5.45M and bringing the position to 261,611 shares worth $5.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1033.
Neuberger Berman Group first reported a position in CC in Q3 2015 and has held it in 34 quarters since. The position peaked at $25.4M in Q1 2019. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Neuberger Berman Group held 261,611 shares of Chemours worth $5.37M as of Q2 2026.
- Neuberger Berman Group bought 237,939 Chemours shares in Q2 2026, an estimated $5.45M.
- Chemours made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1033 holding.
- Neuberger Berman Group first reported a position in Chemours in Q3 2015 and has held it in 34 quarters since.
- Neuberger Berman Group's Chemours position peaked at $25.4M in Q1 2019.
- 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.